Breast tumors lacking BRCA-1 tend to be triple-negative (TNBC) basal-like characterized by reduced expression of estrogen receptor-α (ERα), progesterone receptor (PR), and epidermal growth factor receptor-2 (HER-2) [7]. This evidence concerns the gene ERBB2 and breast neoplasm.